cytidine diphosphate choline has been researched along with Innate Inflammatory Response in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agnifili, L; Aloia, R; Brescia, L; Ferrante, C; Figus, M; Mastropasqua, L; Orlando, G; Rossi, GCM; Sacchi, M | 1 |
| Chen, Q; Gao, Y; Guo, L; Jiang, H; Xu, M; Zhang, F; Zhou, F | 1 |
| Berga, S; Kochanek, PM; Kumar, RG; Santarsieri, M; Wagner, AK | 1 |
| Eisenach, JC; Gurun, MS; Parker, R; Vincler, M | 1 |
| Bian, XX; Qi, CP; Yuan, XS | 1 |
| Bagdas, D; Gurun, MS; Hamurtekin, E; Sonal, S; Sonat, FA | 1 |
1 trial(s) available for cytidine diphosphate choline and Innate Inflammatory Response
| Article | Year |
|---|---|
Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
Topics: Adolescent; Adult; Aged; Brain Injuries; Case-Control Studies; Cohort Studies; Cytidine Diphosphate Choline; Double-Blind Method; Fas Ligand Protein; Female; Glasgow Outcome Scale; Humans; Hydrocortisone; Hypothermia, Induced; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Nootropic Agents; Prognosis; Prospective Studies; Trauma Severity Indices; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
5 other study(ies) available for cytidine diphosphate choline and Innate Inflammatory Response
| Article | Year |
|---|---|
Citicoline/Coenzyme Q10/Vitamin B3 Fixed Combination Exerts Synergistic Protective Effects on Neuronal Cells Exposed to Oxidative Stress.
Topics: Brain-Derived Neurotrophic Factor; Cytidine Diphosphate Choline; Dopamine; Humans; Inflammation; Interleukin-6; Niacinamide; Oxidative Stress; Tumor Necrosis Factor-alpha; Ubiquinone | 2022 |
CDP-choline modulates cholinergic signaling and gut microbiota to alleviate DSS-induced inflammatory bowel disease.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Choline; Colitis; Colon; Cytidine Diphosphate Choline; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Nicotinic Antagonists | 2023 |
The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation; Injections; Male; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Effect of recombinant human erythropoietin on serum S100B protein and interleukin-6 levels after traumatic brain injury in the rat.
Topics: Animals; Brain Injuries; Cytidine Diphosphate Choline; Dose-Response Relationship, Drug; Erythropoietin; Humans; Inflammation; Interleukin-6; Male; Nerve Growth Factors; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors | 2010 |
The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Choline; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation; Male; Neuralgia; Pain; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, Nicotinic; Receptors, Opioid; Time Factors | 2011 |